Cannabis has been used for thousands of years as a treatment for a variety of medical conditions. Today, it is filling an urgent need in the form of a safe and effective treatment alternative, where conventional medications might fail. The plant’s compounds (cannabinoids) interact with our body’s natural endocannabinoid system (ECS), which manages several functions, such as pain, mood, sleep and appetite. Many doctors are still working to understand the ECS in relation to alternative medicines and may be unfamiliar or sceptical about it. Further compounded by the way this new industry consolidates medical cannabis under the umbrella of street cannabis, hemp and CBD oil. However with the change in regulation across the world, we see an increasingly better understanding of medical cannabis and growing clinical and anecdotal evidence that show the positive impact it could have in managing chronic conditions.
Medical cannabis (or medical marijuana as it is also known) is derived
from the cannabis plant and bred specifically to use the plant’s
therapeutic properties, to treat a number of conditions. The plant contains
over 100 compounds that are called cannabinoids and mimic the naturally
occurring cannabinoids found within the human body. The most common
and abundant cannabinoids are cannabidiol (CBD) and
tetrahydrocannabinol (THC). There is increasing research and clinical
evidence indicating that these compounds could help to relieve the
symptoms of many chronic conditions. The therapeutic and pain-relieving
properties of medical cannabis are the reason why increasing numbers of
people consider it as alternative treatment for their ailments.
Medical cannabis contains over 100 different cannabinoids, which interact
with the body’s natural endocannabinoid system (ECS). The ECS is a
complex cell-signalling system in the human body which helps to regulate
functions such as sleep, pain, mood, and appetite. It’s primary function is
to ensure your body stays in homeostasis or balance. If the stability of
your internal environment is thrown off by injury or fever for example, this
will lead to your ECS responding to help your body to return to its natural
balance. The ECS involves three core components: endocannabinoids,
receptors, and enzymes. Endocannabinoids are molecules made by our
bodies and help keep certain bodily functions running smoothly. They bind
to receptors that are found throughout your whole body to signal that the
ECS needs to act. And enzymes break down endocannabinoids once
they’ve carried out their function. The two main endocannabinoid
receptors are CB1 (found in the central nervous system) and CB2 found in
the peripheral nervous system, especially immune cells.
Endocannabinoids might target CB1 receptors in a spinal nerve to relieve
pain, while others might bind to a CB2 receptor in your immune cells to
signal that your body’s experiencing inflammation, a common sign of
autoimmune disorders. The plant cannabinoids found in cannabis can
interact with the ECS and therefore have the potential to impact bodily
functions that the ECS controls, including appetite, metabolism, nerve
function, pain, inflammation, mood, brain function and cardiovascular
system function. While evidence and research of the interaction between
the ECS and medical cannabis is growing, most doctors are not yet
considering it as a valid alternative treatment possibility for chronic
conditions. We are here to bridge this gap and can mediate the
conversation with your doctor.
Canntab is setting the pharmaceutical-grade-standard for medical/therapeutic cannabis product quality and safety.
Quality assurance is at the core of every formulation we create and each shipment we make. Our team is led by experienced professionals who have built their extensive careers in areas such as the manufacturing of pharmaceutical medicines and the implementation of cutting-edge laboratory technologies.
These dedicated professionals ensure product quality and patient safety, with an emphasis on the reporting, analysis, and prevention of medical errors. For more information on our dedicated professionals, please visit Our Leadership Team.
Bioavailability is the extent to which a substance or drug, as a function of absorption, becomes available to the intended destination in your body.
Nanotechnology is the use of matter on an atomic, molecular, and supramolecular scale for industrial and medical purposes, as in nanomedicine. One of the best applications of nanomedicine is in the area of drug delivery, whereby nanoparticles deliver substances directly to specific cells.
At Canntab, our scientists and formulation experts combine nanotechnology with CBD and THC molecules to create products that improve the bioavailability of these elements in your body. These safe, stable materials are produced on a nanoscale (microscopically small) and optimize the oral route of administration for all of our products.
Canntab’s arrival heralds a new paradigm bringing a truly pharmaceutical
approach to quality product development and formulations. By innovating
the formulation of medical cannabis into hard tablets and caplets, Canntab
brings the convenience people are accustomed to.
In every aspect of our business, we bring a level of rigorous operational
control that ensures purity and precision. Canntab products are a cut
above other medical cannabis options – our patented process, which
incorporates nanotechnology to increase bioavailability – offers our
customers greater control over their medical cannabis experience